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Abstract 
The 4-O-sulfuric esters of methyl 6-deoxy-α-L-talo- and -α-L-mannopyranoside were prepared. 
The first ester is a component of the glycopeptidolipid-type cell surface antigens of M. avium. 
The isosteric isomers (sugar-4-CH2-SO3Na) of both sulfate esters (sugar-4-O-SO3Na) were 
synthesized using free radical addition reactions between sugar-exomethylene derivatives and 
either thioacetic acid or NaHSO3. The addition products of thioacetic acid were converted into 
sugar-CH2-sulfonic acids by oxidation with oxone. Characteristic 1H- and 13C-NMR data are 
given and discussed. 
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Introduction 
 
Most species of Mycobacterium are saprophytic species found in soil and some of them are 
serious human health threats.1 Besides Mycobacterium tuberculosis2 and M. leprae3,4, the agents 
of human tuberculosis and leprosy, respectively, other 'atypical' or 'opportunistic' mycobacteria 
may also cause infections in humans.5 Infections with the M. avium serocomplex are seen in up 
to 50% of the patients with AIDS in some areas of the world .6-8  
Mycobacterial diseases are difficult to treat,9 and this is directly related to the unusual 
complex structure of the cell-wall9,10 of the organism. The cell-wall presents a formidable 
barrier11 to the passage of antibiotics into the organism. The combination of different antibiotics 
can slowly destroy the integrity of the cell-wall and allow other antibiotics to pass into the 
organism more easily. 
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The mycobacterial cell-wall has five major components: 10,11 
i) the plasma membrane; 
ii) peptidoglycan; 
iii) the mycolyl-arabinogalactan (AG), both sugars are in furanosyl form in the  
polysaccharide; 
iv) lipoarabinomannan (LAM) and lipomannan (LM) ; 
v) glycolipids noncovalently bound to the large amount of mycolate esters. Because these 
glycolipids are on the outermost surface of the bacteria, these outer oligosaccharide haptens are 
responsible for the immunological properties of the bacteria. Thus, these haptens, after 
conjugation with suitable proteins, might aid the serodiagnosis of mycobacterial infections.12,13 
These haptens, which are oligosaccharides, have very different, and very often exotic 
structures for the monosaccharide units. They are mainly deoxy sugars and contain many O-
methyl substituents. Acyl groups also are present and pyruvic acid is common in acetalic form. 
These serospecific oligosaccharides glycosylate different "core" regions. Basically, these so-
called extractable lipids, which contain the immunospecific oligosaccharides, can be classified 
into four groups:12,13 glycopeptidolipids, lipooligosaccharides, phenolic glycolipids, and acylated 
trehalose derivatives. 
The human pathogens M. tuberculosis and M. avium produce sulfated glycolipids and 
recently it was shown that the very conservative core region of glycopeptidolipids is also sulfated 
at position 4 of the 6-deoxy-L-talose of M. avium14 and the 3,4-di-O-methyl-L-rhamnose at 
position 2 in the case of M. fortuitum.15 It is worth mentioning that the 4-O-sulfated 6-deoxy-L-
talose was isolated from an ethambutol-resistant M. avium strain cultured from a patient with 
AIDS.14 
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Figure 1 
 
The biological role of sugar sulfate esters16,17 and sugar C-sulfonic acids18-20 cannot be 
overestimated. Sulfated sugars are common mediators of cell-cell and host-pathogen interactions. 
In our program, we wished to replace the sugar sulfate esters by sugar sulfonic acids and by 
sugar-methylene-sulfonic acids. Such investigations were accomplished in the case of sialyl 
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Lewis X21,22 and Helicobacter pylori ligand analogs.23 We developed new methods for the 
preparation of sugar sulfonic acids24,25 and we supposed that sugar methylene-sulfonic acids, 
which are isosteric analogs of sugar sulfates, might be better replacements for sugar O-sulfates 
than sugar sulfonic acids. 
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Figure 2 
 
In this paper we wish to report on the syntheses of methyl 6-deoxy-4-O-sulfate-α-L-
talopyranoside, its C-4-epimer derivative, methyl 4,6-dideoxy-4-C-methylene-sulfonic acid-α-L-
talopyranoside, and methyl 4,6-dideoxy-4-C-(sodium methylene-sulfonic acid)-α-L-
mannopyranoside. 
 
Results and Discussion  
The reagents most frequently employed for sulfation are complexes of sulfur trioxide with a 
tertiary amine (e.g. trimethylamine or pyridine) or an amide (formamide or dimethylformamide) 
in pyridine, dimethyl sulfoxide or N,N-dimethylformamide as the solvent. Other sulfation 
reagents that can be used are chlorosulfonic acid or piperidine-N-sulfonic acid in a polar, aprotic 
solvent. 
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Scheme 1. a) 10 eq. SO3.py, DMF, 1h; NaHCO3; 77% for 2, 79% for 5; b) 96% AcOH, 30 min., 
quant. 
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Methyl 2,3-O-isopropylidene-α-L-rhamnopyranoside (1)26 was treated with the SO3.Pyridine 
complex in DMF for 1h at room temperature to give methyl 2,3-O-isopropylidene-4-O-(sodium 
sulfonato)-α-L-rhamnopyranoside (2) in 77% yield. Its 13C-NMR spectrum showed the presence 
of a strong deshielding effect, which led to a downfield shift for C-4 of 6.9 ppm. In this case we 
could not detect any upfield shift in the adjacent carbon signals.27 Hydrolysis of the 
isopropylidene group was achieved with acetic acid at room temperature for 30 min and the yield 
was quantitative. In the 13C-NMR spectrum of methyl 4-O-(sodium sulfonato)-α-L-
rhamnopyranoside (3), C-4 resonates at 81.1 ppm. This α-shift is 8.2 ppm. The 13C-NMR data 
for methyl α-L-rhamnopyranoside and for compound 1 were published previously by 
Argentinean authors.28 
Similar treatment of methyl 6-deoxy-2,3-O-isopropylidene-α-L-talopyranoside (4)29 with the 
SO3.Pyridine complex resulted in methyl 6-deoxy-2,3-O-isopropylidene-4-O-(sodium sulfonato)-
α-L-talopyranoside (5). Comparing the 13C-NMR spectra of compounds 5 and 4,30 a very large 
downfield shift of 13.5 ppm was observed at C-4 and there was a considerable upfield shift (6.9 
ppm) at C-3. 
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Scheme 2. a) 5 eq. AcSH, AIBN, toluene, 80°C, 8h, 22% 8:9=1:1; b) 2.5 eq. oxone, 20 eq. 
KOAc, AcOH, 54% for 10, 69% for 11; c) 96% AcOH, 60°C, 1h, quant. 
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Precise prediction of 13C chemical shifts is rather difficult, as various factors, such as 
conformational distortions and steric crowding of the substituents may influence the molecular 
environment of the individual carbon atoms. Hydrolysis of the isopropylidene acetal resulted in 
the target compound 6 with quantitative yield. The 13C chemical shifts are in the normal region, 
the value for C-4 is 80.1 ppm, and the α-shift is 7.3 ppm. The 13C-NMR spectrum of methyl 6-
deoxy-α-L-talopyranoside was measured in CDCl3.31 
For the preparation of the 4-deoxy-4-C-(sodium sulfonatomethyl) derivatives 10 and 12 of 
methyl α-L-rhamnopyranoside or methyl 6-deoxy-α-L-talopyranoside, methyl 4,6-dideoxy-2,3-
O-isopropylidene-4-C-methylene-α-L-lyxo-hexopyranoside32 (7) was used. The synthesis of the 
latter from methyl 6-deoxy-2,3-O-isopropylidene-α-L-lyxo-hexopyran-4-uloside29 using Tebbe's 
reagent33 was accomplished according to the van Boom methodology.34 
The well-known photoaddition reaction of cysteamine to allyl35 groups, which leads to the 
corresponding amino-thioethers, was applied for the synthesis of a pentavalent glycoclaster.36 A 
similar radical photoaddition catalysed by AIBN also was reported with perbenzylated exocyclic 
glycals in benzene solution using freshly distilled thioacetic acid at reflux temperature; only the 
ß-C-glycoside (1-S-acetyl-2,6-anhydro-1-deoxy-3,4,5,7-tetra-O-benzyl-D-glycero-D-gulo- 
heptitol) was formed in 82% yield. To the best of our knowledge, radical addition reactions with 
uloso-sugars have not been published previously. 
The AIBN or ABCN catalysed free radical addition reaction between compound 7 and 
thioacetic acid in toluene resulted in a 1:1 mixture of methyl 4,6-dideoxy-2,3-O-isopropylidene-
4-C-(acetylthiomethyl)-α-L-mannopyranoside (8) and -α-L-talopyranoside (9). The yield was 
very low (22%) even at high temperature (80ºC) and after a long reaction time (8h). The C-4 
epimers could be separated, and their chirality also could be determined by measuring the values 
of the 3JH4,H5 coupling constants (10.1 Hz for 8 and 6.9 Hz for 9). The COSY and HETCOR 1H- 
and 13C-NMR spectra and Mw measurements for compounds 8 and 9 using ESI-TOF verified the 
postulated structures. Some very characteristic 13C-NMR data are worthy of mention: the C-4 
resonance of the manno-isomer (8) is at 44.1 ppm, whereas, in the case of the talo-isomer (9), it 
is at higher field (36.4 ppm). The CH2-groups in each compound resonate nearly at the same 
fields (27.6 and 27.8 ppm).  
Oxidation of compound 8 with oxone38 resulted in the methylene-sulfonic acid potassium salt 
(10). Analogous treatment of compound 9 gave the talo-isomer 11. The carbon NMR spectra for 
both isomers (10 and 11) showed the same C-4 chemical shift values and the differences which 
were observed for the C-4 epimers of the thioacetates 8 and 9. 
Hydrolysis of the isopropylidene group in compound 10 using acetic acid resulted in a 
quantitative yield of 12, and similarly compound 11 yielded 13. Interestingly, the chemical shift 
values of the epimeric C-4's are nearly the same (42.3 and 41.9 ppm), but a considerable 
difference was observed for the CH2-group-values (51.5 and 47.0 ppm). 
 
 
 
Issue in Honor of Prof. Sándor Antus ARKIVOC 2004 (vii) 196-207 
ISSN 1424-6376 Page 201 ©ARKAT USA, Inc 
c
ba
16 
15
OHH2C OH
OMe
O
7
14
O
OMe
OO
NaO3S
7
OH
AcS
OH
OMe
O
 
 
Scheme 3. a) CF3COOH, H2O, DCM, 1h, 73%; b) 5 eq. AcSH, AIBN, toluene, 80°C, 8h, 17%; 
t-butyl peroxybenzoate, NaHSO3, EtOH-H2O, reflux, 56%. 
 
It was mentioned earlier that the thioacetic acid addition to the perbenzylated exocyclic 
glycal resulted only in the equatorial methylene-thioacetate derivative. To clear up the role of 
the isopropylidene acetal in compound 7, we hydrolysed the isopropylidene group and the 
resulting methyl 4,6-dideoxy-4-C-exomethylene-α-L-lyxo-hexopyranoside (14) was treated with 
thioacetic acid in the presence of AIBN catalyst. Surprisingly, only one isomer was formed and it 
proved to be methyl 4,6-dideoxy-4-C-(acetylthiomethyl)-α-L-mannopyranoside (15) which is the 
equatorial isomer. Unfortunately, the yield was again very low (17%) and it could not be 
increased. It seems very propable that the uloso-glycosides also react in a radical addition 
reaction, and the photoaddition leads mainly to the equatorial product. The flexible conformation 
of the unsaturated compound is an important prediction. This assumption was also supplied by 
the fact that hydrogensulfite addition catalysed by tert-butyl peroxybenzoic acid resulted 
exclusively in compound 16. This observation is in a good accordance with earlier results where 
the authors 39-41 allowed methyl 6-deoxy-α- and ß-D-xylo-hex-5-enopyranoside, methyl 6-deoxy-
ß- and -α-L-arabino-hex-5-enopyranoside and methyl 6-deoxy-α-D-lyxo-hex-5-enopyranoside to 
react with hydrogen sulfite in aqueous solution. The main or exclusive products were the D-
sugars in which the 6-sulfonate moieties were in an equatorial position. 
In conclusion, we have demonstrated that the isosteric analogs of compounds 3 and 6, 
which are sugar-O-sulfates, could be obtained from sugar exomethylene derivatives by radical 
addition reactions using either thioacetic acid or sodium hydrogen sulfite. 
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Experimental Section 
 
General Procedures. Optical rotations were measured at room temperarure with a Perkin-Elmer 
241 automatic polarimeter in CHCl3, MeOH and H2O. TLC was performed on Kieselgel 60 F254 
(Merck) with detection by charring with 50% aqueous sulfuric acid. Column chromatography 
was performed on Silica gel 60 (Merck 63-200 mesh). The 1H (200, 360 and 500 MHz) and 13C 
NMR (50.3, 90.54, 125.76 MHz) spectra were recorded with Bruker WP-200 SY, Bruker AM-
360 and Bruker DRX-500 spectrometers. Internal references: TMS (0.00 ppm for 1H for organic 
solutions), CDCl3 (77.00 ppm for 13C), MeOH-d4 (49.05 ppm for 13C) and DSS (0.00 ppm for 1H 
for aqueous solutions). MALDI-TOF MS analyses of the compounds were performed in the 
positive-ion mode using a Bruker Biflex MALDI-TOF mass spectrometer equipped with 
delayed-ion extraction. Desorption/ionization of the sample molecules was effected with a 
337 nm nitrogen laser. The spectrum was performed in 2,5-dihydroxybenzoic acid (DHB) matrix 
by mixing 0.5 µl of the matrix solution with 0.5 µl of the sample on the target and it was allowed 
to dry at room temperature. Identification of the compounds was done on the basis of the mass of 
the [M+Na]+ peak. ESI-MS analyses of the compounds were performed in the negative-ion mode 
using Bruker BIOTOF II. Elemental analyses were performed at the analytical laboratories of the 
University of Debrecen. 
 
Methyl 2,3-O-isopropylidene-4-O-(sodium sulfonato)-α-L-rhamnopyranoside (2). A 
solution of 1 (1.0 g, 4.58 mmol) in DMF (30 mL) was treated with the SO3⋅Py complex (7.3 g, 
46.0 mmol) for 1 h at rt, then cold saturated NaHCO3 solution was added in excess (pH > 7). The 
resulting mixture was concentrated in vacuo. Then, MeOH (100 ml) was added and after stirring 
for 20 min., the insolubles were removed by filtration. The filtrate was concentrated under 
reduced pressure and then purified on a column of silica gel (DCM-MeOH 9:1) to give (1.13 g, 
3.53 mmol) of 2 (77 %). [α]D = -21.5 (c=0.29 in MeOH). Rf = 0.51 (DCM-MeOH 8:2). 
NMR data: δH (CD3OD) 4.79 (s, 1H, H1), 4.23 (t, 1H, J(3,4) = 3.3 Hz, H3), 4.15 (dd, 1H, J(4,5) 
= 4.9 Hz, H4), 4.11 (dd, 1H, J(2,3) = 2.9 Hz, H2), 3.69 (m, 1H, J(5,6) = 3.2 Hz, H5), 3.38 (s, 3H, 
OMe), 1.54 and 1.35 (2s, 6H, CMe2), 1.36 (d, 3H, CH3(6)). δC (CD3OD) 110.5 (CMe2), 99.5 
(C1), 81.1 (C4), 78.1 (C3), 77.1 (C2), 65.8 (C5), 55.2 (OMe), 28.0 and 26.5 (CMe2), 18.2 (C6). 
Exact mass Calcd.: 320.05. Found: 320.31.  
Methyl 4-O-(sodium sulfonato)-α-L-rhamnopyranoside (3). A solution of 2 (50 mg, 
0.156 mmol) in acetic acid (96 %) (3.0 mL) was stirred for 30 min. at rt, then the mixture was 
concentrated in vacuo to give 3 (quant). [α]D = -79.1 (c=0.18 in MeOH). Rf = 0.45 (DCM-MeOH 
75:25). 
NMR data: δH (CD3OD) 4.60 (s, 1H, H1), 4.26 (t, 1H, J(4,5) = 4.7 Hz, J(3,4) = 4.4 Hz, H4), 3.85 
(m, 2H, H2, H3), 3.66 (m, 1H, J(5,6) = 3.0 Hz, H5), 3.38 (s, 3H, OMe), 1.35 (d, 3H, CH3(6)). δC 
(CD3OD) 102.1 (C1), 81.1 (C4), 71.8 (C2), 71.7 (C3), 67.6 (C5), 55.3 (OMe), 17.9 (C6). Anal. 
Calcd. for C7H13O8SNa (280.23): C, 30.00; H, 4.68. Found: C, 30.01; H, 4.63. 
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Methyl 6-deoxy-2,3-O-isopropylidene-4-O-(sodium sulfonato)-α-L-talopyranoside (5). A 
solution of 4 (1.0 g, 4.58 mmol) in DMF (30 mL) was treated with the SO3⋅Py complex (7.3 g, 
46.0 mmol) for 1 h at rt, then cold saturated NaHCO3 solution was added in excess (pH > 7). The 
resulting mixture was concentrated in vacuo. Then, MeOH (100 ml) was added and, after stirring 
for 20 min., the insolubles were removed by filtration. The filtrate was concentrated under 
reduced pressure and then purified on a column of silica gel (DCM-MeOH 9:1) to give (1.16 g, 
3.62 mmol) of 5 (79 %). [α]D = -59.6 (c=0.36 in MeOH). Rf = 0.41 (DCM-MeOH 8:2).  
NMR data: δH (CD3OD) 4.73 (dd, 1H, J(4,5) = 2.5 Hz, H4), 4.61 (d, 1H, J(1,2) = 1.0 Hz, H1), 
4.57 (dd, 1H, J(3,4) = 1.9 Hz, H3), 4.09 (dd, 1H, J(2,3) = 3.3 Hz, H2), 4.18 (m, 1H, H5), 3.42 (s, 
3H, OMe), 1.55 and 1.34 (2s, 6H, CMe2), 1.41 (d, 3H, J(5,6) = 3.3 Hz, CH3(6)). δC (CD3OD) 
111.6 (CMe2), 100.3 (C1), 76.4 (C2), 74.3 (C3), 72.4 (C4), 67.3 (C5), 56.0 (OMe), 26.7 and 25.5 
(CMe2), 17.4 (C6). Exact mass Calcd.: 320.05. Found: 320.32.  
Methyl 6-deoxy-4-O-(sodium sulfonato)-α-L-talopyranoside (6). A solution of 5 (50 mg, 
0.156 mmol) in acetic acid (96 %) (3.0 mL) was stirred for 30 min. at rt, then the mixture was 
concentrated in vacuo to give 6 (quant). [α]D = -66.6 (c=0.15 in H2O). Rf = 0.45 (DCM-MeOH 
75:25).  
NMR data: δH (D2O) 4.73 (d, 1H, J(1,2) = 1.5 Hz, H1), 4.51 (dd, 1H, J(4,5) = 1.0 Hz, H4), 4.05 
(m, 1H, H5), 3.92 (t, 1H, J(3,4) = 3.5 Hz, H3), 3.67 (dd, 1H, J(2,3) = 3.5 Hz, H2), 3.37 (s, 3H, 
OMe), 1.31 (d, 3H, J(5,6) = 6.5 Hz, CH3(6)). δC (D2O) 102.9 (C1), 80.1 (C4), 69.2 (C2), 66.4 
(C5), 66.2 (C3), 55.8 (OMe), 17.1 (C6). Anal. Calcd. for C7H13O8SNa (280.23): C, 30.00; H, 
4.68. Found: C, 29.95; H, 4.65. 
Methyl 4-deoxy-2,3-O-isopropylidene-4-C-(acetylthiomethyl)-α-L-rhamnopyranoside (8) 
and methyl 4,6-dideoxy-2,3-O-isopropylidene-4-C-(acetylthiomethyl)-α-L-talopyranoside 
(9). To a solution of 7 (1.00 g, 4.67 mmol) in toluene (50 mL) was added thioacetic acid 
(1.67 ml, 23.4 mmol) and AIBN (112 mg, 0.460 mmol). The solution was stirred at 80 oC for 4 h. 
The solvent was removed in vacuo and the crude product was then purified on a column of silica 
gel (DCM- EtOAc 99:1) to give (150 mg, 0.52 mmol) of 8 (11 %) and (150 mg, 0.52 mmol) of 9 
(11 %).  
8. [α]D = -21.8 (c=0.46 in CHCl3). Rf = 0.41 (DCM-EtOAc 97:3). 
NMR data: δH (CDCl3) 4.83 (s, 1H, H1), 3.95 (m, 2H, H2, H3), 3.54 (m, 1H, J(4,5) = 10.1 Hz, 
H5), 3.34 (s, 3H, OMe), 3.20 (dd, 1H, 3J(4,A) = 4.0, 2J(A,B) = 13.8, CH2A), 2.98 (dd, 1H, 3J(4,B) 
= 5.0, CH2B), 2.30 (s, 3H, SAc), 1.75 (m, 1H, H4), 1.45 and 1.30 (2s, 6H, CMe2), 1.20 (d, 3H, 
J(5,6) = 6.1 Hz, CH3(6)). δC (CDCl3) 108.9 (CMe2), 98.1 (C1), 74.1, 73.6 (skeleton C), 64.5 
(C5), 54.8 (OMe), 44.1 (C4), 30.6 (SAc), 28.1 and 26.2 (CMe2), 27.6 (CH2), 18.6 (C6). Anal. 
Calcd. for C13H22O5S (290.38): C, 53.77; H, 7.64. Found: C, 53.71; H, 7.60. 
9. [α]D = -46.6 (c=0.45 in CHCl3). Rf = 0.33 (DCM-EtOAc 97:3). 
NMR data: δH (CDCl3) 4.53 (d, 1H, J(1,2) = 2.5 Hz, H1), 4.40 (dd, 1H, J(3,4) = 3.2 Hz H3), 4.08 
(m, 1H, J(4,5) = 6.9 Hz, H5), 3.92 (dd, 1H, J(2,3) = 7.0 Hz, H2), 3.38 (s, 3H, OMe), 3.05 (dd, 
1H, 3J(4,A) = 7.0, 2J(A,B) = 13.5, CH2A), 2.92 (dd, 1H, 3J(4,B) = 8.5, CH2B), 2.33 (m, 1H, H4), 
2.31 (s, 3H, SAc), 1.46 and 1.28 (2s, 6H, CMe2), 1.32 (d, 3H, J(5,6) = 6.7 Hz, CH3(6)). δC 
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(CDCl3) 109.5 (CMe2), 98.8 (C1), 74.7, 73.1 (skeleton C), 67.9 (C5), 55.8 (OMe), 36.4 (C4), 
30.7 (SAc), 27.8 (CH2), 26.8 and 24.8 (CMe2), 17.5 (C6). Anal. Calcd. for C13H22O5S (290.38): 
C, 53.77; H, 7.64. Found: C, 53.69; H, 7.55. 
 
Methyl 4-deoxy-2,3-O-isopropylidene-4-C-(potassium sulfonatomethyl)-α-L-rhamnopyranoside 
(10). To a stirred solution of 8 (50 mg, 0.172 mmol) in glacial acetic acid (3 mL) were added 
potassium acetate (338 mg, 3.44 mmol) and OXONE (2KHSO5, KHSO4, K2SO4) (264 mg, 
0.43 mmol). After 16 h at room temperature, the mixture was diluted with cold water (3 mL), 
and cold saturated NaHCO3 solution was added in excess (pH > 7). The resulting mixture was 
concentrated in vacuo. Then, MeOH (10 ml) was added and, after stirring for 20 min., the 
insolubles were removed by filtration. The filtrate was concentrated under reduced pressure and 
then purified on a column of silica gel (DCM-MeOH 9:1) to give (31 mg, 0.093 mmol) of 10 
(54 %). [α]D = -57.8 (c=0.37 in MeOH). Rf = 0.65 (DCM-MeOH 75:25). 
NMR data: δH (CD3OD) 4.79 (s, 1H, H1), 4.75 (dd, 1H, J(3,4) = 9.0 Hz H3), 4.08 (m, 1H, J(4,5) 
= 9.3 Hz, H5), 3.97 (d, 1H, J(2,3) = 5.3 Hz, H2), 3.36 (s, 3H, OMe), 3.15 (dd, 1H, 3J(4,A) = 4.3, 
2J(A,B) = 14.7, CH2A), 3.03 (dd, 1H, 3J(4,B) = 4.4, CH2B), 1.92 (m, 1H, H4), 1.47 and 1.32 (2s, 
6H, CMe2), 1.34 (d, 3H, J(5,6) = 6.3 Hz, CH3(6)). δC (CDCl3) 110.0 (CMe2), 99.9 (C1), 75.2, 
75.0 (skeleton C), 66.7 (C5), 55.3 (OMe), 50.6 (CH2), 43.7 (C4), 28.5 and 26.7 (CMe2), 20.0 
(C6). Anal. Calcd. for C11H19O7SK (334.43): C, 39.51; H, 5.73. Found: C, 39.50; H, 5.65.  
Methyl 4-deoxy-4-C-(potassium sulfonatomethyl)-α-L-rhamnopyranoside (12). A solution 
of 10 (20 mg, 0.0598 mmol) in acetic acid (96 %) (1.5 mL) was stirred at 60 oC for 1 h, then the 
mixture was concentrated in vacuo to give 12 (quant). [α]D = -67.6 (c=0.31 in MeOH). Rf = 0.35 
(DCM-MeOH 7:3). 
NMR data: δH (CD3OD) 4.63 (d, 1H, J(1,2) = 1.5 Hz, H1), 3.94 (dd, 1H, J(3,4) = 10.9 Hz, H3), 
3.81 (m, 1H, J(4,5) = 10.4 Hz, H5), 3.72 (dd, 1H, J(2,3) = 3.2 Hz, H2), 3.33 (s, 3H, OMe), 3.00 
(d, 2H, CH2A, CH2B), 2.16 (m, 1H, H4), 1.33 (d, 3H, J(5,6) = 6.2 Hz, CH3(6)). δC (CD3OD) 
102.7 (C1), 70.9 (C3), 70.5 (C2), 68.7 (C5), 55.2 (OMe), 51.5 (CH2), 42.3 (C4) 19.4 (C6). Exact 
mass Calcd.: 294.018. Found: 294.093.  
Methyl 4,6-dideoxy-2,3-O-isopropylidene-4-C-(potassium sulfonatomethyl)-α-L- 
talopyranoside (11). To a stirred solution of 9 (50 mg, 0.172 mmol) in glacial acetic acid (3 mL) 
were added potassium acetate (338 mg, 3.44 mmol) and OXONE (2KHSO5, KHSO4, K2SO4) 
(264 mg, 0.43 mmol). After 16 h at room temperature, the mixture was diluted with cold water 
(3 mL), and cold saturated NaHCO3 solution was added in excess (pH > 7). The resulting 
mixture was concentrated in vacuo. Then, MeOH (10 ml) was added and, after stirring for 
20 min., the insolubles were removed by filtration. The filtrate was concentrated under reduced 
pressure and then purified on a column of silica gel (DCM-MeOH 9:1) to give (40 mg, 
0.120 mmol) of 11 (69 %). [α]D = -60.6 (c=0.16 in MeOH). Rf = 0.55 (DCM-MeOH 75:25). 
NMR data: δH (CD3OD) 4.67 (dd, 1H, J(3,4) = 2.5 Hz, H3), 4.52 (d, 1H, J(1,2) = 3.2 Hz, H1), 
4.27 (m, 1H, J(4,5) = 6.7 Hz, H5), 3.92 (dd, 1H, J(2,3) = 7.0 Hz, H2), 3.42 (s, 3H, OMe), 2.95 
(m, 3H, H4, CH2A, CH2B), 1.47 and 1.30 (2s, 6H, CMe2), 1.39 (d, 3H, J(5,6) = 6.5 Hz, CH3(6)). 
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δC (CD3OD) 110.8 (CMe2), 100.2 (C1), 76.4, 75.7 (skeleton C), 70.3 (C5), 56.5 (OMe), 51.7 
(CH2), 34.6 (C4), 27.6 and 25.3 (CMe2), 17.8 (C6). Anal. Calcd. for C11H19O7SK (334.43): C, 
39.51; H, 5.73. Found: C, 39.44; H, 5.64. 
Methyl 4,6-dideoxy-4-C-(potassium sulfonatomethyl)-α-L-talopyranoside (13). A solution of 
11 (20 mg, 0.0598 mmol) in acetic acid (96 %) (1.5 mL) was stirred at 60 oC for 1 h, then the 
mixture was concentrated in vacuo to give 13 (quant). [α]D = -53.5 (c=0.16 in MeOH). Rf = 0.35 
(DCM-MeOH 7:3). 
NMR data: δH (CD3OD) 4.65 (d, 1H, J(1,2) = 3.1 Hz, H1), 4.14 (m, 1H, J(4,5) = 3.4 Hz, H5), 
4.03 (t, 1H, J(3,4) = 4.1 Hz, J(2,3) = 4.1 Hz, H3), 3.56 (m, 2H, CH2A, H2), 3.38 (s, 3H, OMe), 
3.00 (dd, 1H, 3J(4,A) = 6.2, 3J(4,B) = 4.4, CH2B), 2.39 (m, 1H, H4), 1.33 (d, 3H, J(5,6) = 6.7 Hz, 
CH3(6)). δC (CD3OD) 102.4 (C1), 71.5 (C2), 70.2 (C3), 68.6 (C5), 55.6 (OMe), 47.0 (CH2), 41.9 
(C4), 18.1 (C6). Exact mass Calcd.: 294.018. Found: 294.098.  
Methyl 4,6-dideoxy-4-C-methylene-α-L-lyxo-hexopyranoside (14). To a stirred solution of 7 
(900 mg, 4.20 mmol) in 90 mL of CH2Cl2, 9 mL of trifluoroacetic acid and one drop of water 
were added. After 1 h, the mixture was washed with saturated NaHCO3 solution (15 ml) and H2O 
(15 ml), dried and evaporated to give (534 mg, 3.06 mmol) of 14 (73 %). [α]D = -132.8 (c=0.88 
in MeOH). Rf = 0.46 (DCM-acetone 8:2). 
NMR data: δH (CD3OD) 5.22 and 5.06 (2H, CH2) 4.61 (d, 1H, H1), 4.37 (d, 1H, H3), 4.26 (q, 
1H, H5), 3.75 (dd, 1H, H2), 3.39 (s, 3H, OMe), 1.35 (d, 3H, CH3(6)). δC (CD3OD) 149.0 (Cq), 
108.1 (CH2=), 103.1 (C1), 73.3, 70.3, 67.1 (skeleton C), 55.6 (OMe), 17.4 (C6). Anal. Calcd. for 
C8H14O4 (174.20): C, 55.16; H, 8.10. Found: C, 55.10; H, 8.03. 
Methyl 4,6-dideoxy-4-C-(acetylthiomethyl)-α-L-mannopyranoside (15). To a solution of 14 
(500 mg, 2.87 mmol) in toluene (20 ml) was added thioacetic acid (1.03 ml, 14.35 mmol) and 
AIBN (50 mg, 0.205 mmol). The solution was stirred at 80 oC for 4 h. The solvent was removed 
in vacuo and the crude product was then purified on a column of silica gel (DCM-MeOH 97:3) 
to give (122 mg, 0.488 mmol) of 15 (17 %). [α]D = -48.5 (c=1.11 in MeOH). Rf = 0.55 
(DCM:MeOH 92:8). NMR data: δH (CD3OD) 4.56 (s, 1H, H1), 3.68-3.58 (m, 3H, H2, H3, H5), 
3.32 (s, 3H, OMe), 3.28 (dd, 1H, 3J(4,A) = 3.9, 2J(A,B) = 14.0, CH2A), 3.15 (dd, 1H, 3J(4,B) = 
3.5, CH2B), 2.33 (s, 3H, SAc), 1.94 (m, 1H, H4), 1.23 (d, 3H, J(5,6) = 6.3 Hz, CH3(6)). δC 
(CD3OD) 103.1 (C1), 70.8, 68.8, 68.0 (skeleton C), 55.3 (OMe), 44.3 (C4), 30.7 (SAc), 27.7 
(CH2), 19.4 (C6). 
Anal. Calcd. for C10H18O5S (250.31): C, 47.98; H, 7.25. Found: C, 47.90; H, 7.20. 
Methyl 4-deoxy-2,3-O-isopropylidene-4-C-(sodium sulfonatomethyl)-α-L-rhamnopyranoside 
(16). A solution of 7 (113 mg, 0.527 mmol) in 70 % EtOH (40 ml) was treated with NaHSO3 
(520 mg) and tert-butyl peroxybenzoate (48 µl) and then the mixture was heated under reflux for 
4 h. After cooling, removal of the solvent from the reaction mixture furnished a residue that was 
purified by silica gel column chromatography (DCM-MeOH 9:1) to give (94 mg, 0.295 mmol) 
16 (56 %). [α]D = -60.3 (c=0.85 in MeOH). Rf = 0.35 (DCM-MeOH 7:3). 
NMR data: δH (CD3OD) 4.63 (d, 1H, J(1,2) = 1.5 Hz, H1), 3.94 (dd, 1H, J(3,4) = 10.9 Hz, H3), 
3.81 (m, 1H, J(4,5) = 10.4 Hz, H5), 3.72 (dd, 1H, J(2,3) = 3.2 Hz, H2), 3.33 (s, 3H, OMe), 3.00 
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(d, 2H, CH2A, CH2B), 2.16 (m, 1H, H4), 1.33 (d, 3H, J(5,6) = 6.2 Hz, CH3(6)). δC (CD3OD) 
102.7 (C1), 70.9 (C3), 70.5 (C2), 68.7 (C5), 55.2 (OMe), 51.5 (CH2), 42.3 (C4) 19.4 (C6). Anal. 
Calcd. for C11H19O7SNa (318.32): C, 41.51; H, 6.02. Found: C, 41.47; H, 5.97. 
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